{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:59:31Z","timestamp":1790470771994,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007835","name":"Wenzhou Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007835","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.heliyon.2023.e16916","type":"journal-article","created":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T12:27:25Z","timestamp":1685968045000},"page":"e16916","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["A novel approach to achieve semi-sustained drug delivery to the eye through asymmetric loading of soft contact lenses"],"prefix":"10.1016","volume":"9","author":[{"given":"Malake","family":"Sarmout","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiym","family":"Rakhmetova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6430-4893","authenticated-orcid":false,"given":"Leo H.","family":"Koole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2023.e16916_bib1","first-page":"104","article-title":"Pharmacological and clinical feature of rebamipide: new therapeutic targets","volume":"92","author":"Zvyaglova","year":"2020","journal-title":"Ter. Arkh."},{"key":"10.1016\/j.heliyon.2023.e16916_bib2","article-title":"Secreted mucins on the ocular surface","volume":"59","author":"Hori","year":"2018","journal-title":"Invest. Opthalmol. Vis. Sci."},{"key":"10.1016\/j.heliyon.2023.e16916_bib3","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.survophthal.2021.07.008","article-title":"The role of topical N-acetylcysteine in Ocular therapeutics","volume":"67","author":"Eghtedari","year":"2022","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.heliyon.2023.e16916_bib4","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1089\/jop.2021.0052","article-title":"Benzalkonium chloride-induced corneal epithelial injury in rabbit reduced by rebamipide","volume":"38","author":"Fukuda","year":"2022","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"key":"10.1016\/j.heliyon.2023.e16916_bib5","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.2147\/OPTH.S40798","article-title":"Rebamipide ophthalmic suspension for the treatment of dry eye syndrome: a critical appraisal","author":"Kashima","year":"2014","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.heliyon.2023.e16916_bib6","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1016\/j.ophtha.2012.06.052","article-title":"Rebamipide (OPC-12759) in the treatment of Dry Eye: a randomized, double-masked, multicenter, placebo-controlled phase II study","volume":"119","author":"Kinoshita","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.heliyon.2023.e16916_bib7","doi-asserted-by":"crossref","DOI":"10.1186\/s12886-015-0040-0","article-title":"Effectiveness and relevant factors of 2 % rebamipide ophthalmic suspension treatment in Dry Eye","volume":"15","author":"Ueda","year":"2015","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.heliyon.2023.e16916_bib8","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4103\/ojo.OJO_29_2017","article-title":"Efficacy of rebamipide 2% ophthalmic solution in the treatment of Dry eyes","volume":"11","author":"Shrivastava","year":"2018","journal-title":"Oman J. Ophthalmol."},{"key":"10.1016\/j.heliyon.2023.e16916_bib9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1089\/jop.2016.0096","article-title":"Randomized comparison between Rebamipide ophthalmic suspension and Diquafosol ophthalmic solution for Dry Eye after penetrating keratoplasty","volume":"33","author":"Kobashi","year":"2017","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"key":"10.1016\/j.heliyon.2023.e16916_bib10","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1097\/ICO.0b013e318294f97e","article-title":"Effect of rebamipide ophthalmic suspension on optical quality in the short break-up time type of Dry Eye","volume":"32","author":"Koh","year":"2013","journal-title":"Cornea"},{"key":"10.1016\/j.heliyon.2023.e16916_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/8145731","article-title":"Retrospective observational study on Rebamipide ophthalmic suspension on quality of life of dry eye disease patients","volume":"2019","author":"Sakane","year":"2019","journal-title":"J. Ophthalmol."},{"key":"10.1016\/j.heliyon.2023.e16916_bib12","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.4155\/tde.13.81","article-title":"Soft contact lenses for controlled ocular delivery: 50 years in the making","volume":"4","author":"Gonz\u00e1lez-Chom\u00f3n","year":"2013","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.heliyon.2023.e16916_bib13","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3109\/02713683.2015.1050738","article-title":"Hydrogel Ring for topical drug delivery to the ocular posterior segment","volume":"41","author":"Shikamura","year":"2015","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.heliyon.2023.e16916_bib14","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jconrel.2016.08.025","article-title":"Diffusion of water-soluble sorptive drugs in Hema\/MAA Hydrogels","volume":"239","author":"Liu","year":"2016","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.heliyon.2023.e16916_bib15","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ejpb.2018.04.017","article-title":"Inner layer-embedded contact lenses for PH-triggered controlled ocular drug delivery","volume":"128","author":"Zhu","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.heliyon.2023.e16916_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105591","article-title":"Moxifloxacin-imprinted silicone-based hydrogels as contact lens materials for extended drug release","volume":"156","author":"Silva","year":"2021","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.heliyon.2023.e16916_bib17","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3390\/pharmaceutics13050606","article-title":"Atorvastatin-eluting contact lenses: effects of molecular imprinting and sterilization on drug loading and release","volume":"13","author":"Pereira-da-Mota","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.heliyon.2023.e16916_bib18","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.actbio.2017.01.063","article-title":"Design and optimization of a novel implantation technology in contact lenses for the treatment of dry eye syndrome: in vitro and in vivo evaluation","volume":"53","author":"Maulvi","year":"2017","journal-title":"Acta Biomater."},{"key":"10.1016\/j.heliyon.2023.e16916_bib19","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.3390\/molecules26185577","article-title":"Soft contact lenses as drug delivery systems: a review","volume":"26","author":"Rykowska","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.heliyon.2023.e16916_bib20","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.3390\/polym13071102","article-title":"Contact lenses as ophthalmic drug delivery systems: a review","volume":"13","author":"Franco","year":"2021","journal-title":"Polymers"},{"key":"10.1016\/j.heliyon.2023.e16916_bib21","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.jconrel.2022.06.001","article-title":"Contact lenses for pravastatin delivery to eye segments: design and in vitro-in vivo correlations","volume":"348","author":"Pereira-da-Mota","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.heliyon.2023.e16916_bib22","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jconrel.2022.02.014","article-title":"Testing drug release from medicated contact lenses: the missing link to predict in vivo performance","volume":"343","author":"Pereira-da-Mota","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.heliyon.2023.e16916_bib23","article-title":"In vivo drug delivery via contact lenses: the current state of the field from origins to present","volume":"63","author":"Wuchte","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.heliyon.2023.e16916_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122740","article-title":"Therapeutic contact lenses for the treatment of corneal and ocular surface diseases: advances in extended and targeted drug delivery","volume":"638","author":"Abdi","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.heliyon.2023.e16916_bib25","doi-asserted-by":"crossref","DOI":"10.1089\/jop.2021.0094","article-title":"Transport of vitamin E from ethanol\/water solution into contact lenses and impact on Drug Transport","author":"Liu","year":"2022","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"key":"10.1016\/j.heliyon.2023.e16916_bib26","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1021\/ie0507934","article-title":"Modeling ophthalmic drug delivery by soaked contact lenses","volume":"45","author":"Li","year":"2006","journal-title":"Ind. Eng. Chem. Res."},{"key":"10.1016\/j.heliyon.2023.e16916_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105503","article-title":"Hydrogel-based ocular drug delivery systems for hydrophobic drugs","volume":"154","author":"Torres-Luna","year":"2020","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.heliyon.2023.e16916_bib28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1089\/jop.2012.0212","article-title":"Contact lenses: promising devices for ocular drug delivery","volume":"29","author":"Guzman-Aranguez","year":"2013","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"key":"10.1016\/j.heliyon.2023.e16916_bib29","first-page":"24","volume":"vol. 95","author":"Holgado","year":"2020"},{"key":"10.1016\/j.heliyon.2023.e16916_bib30","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0142-9612(01)00197-1","article-title":"Stability of radiopaque iodine-containing biomaterials","volume":"23","author":"Aldenhoff","year":"2002","journal-title":"Biomaterials"},{"key":"10.1016\/j.heliyon.2023.e16916_bib31","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1021\/acs.molpharmaceut.0c00140","article-title":"In vitro topical delivery of chlorhexidine to the cornea: enhancement using drug-loaded contact lenses and \u03b2-cyclodextrin complexation, and the importance of simulating tear irrigation","volume":"17","author":"Hewitt","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.heliyon.2023.e16916_bib32","series-title":"Q2(R1) Validation of Analytical Procedures","first-page":"127","author":"Borman","year":"2017"},{"key":"10.1016\/j.heliyon.2023.e16916_bib33","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0142-9612(01)00197-1","article-title":"Stability of radiopaque iodine-containing biomaterials","volume":"23","author":"Aldenhoff","year":"2002","journal-title":"Biomaterials"},{"key":"10.1016\/j.heliyon.2023.e16916_bib34","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1021\/bm1010273","article-title":"Versatile polymer microspheres for injection therapy: aspects of fluoroscopic traceability and biofunctionalization","volume":"11","author":"Saralidze","year":"2010","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.heliyon.2023.e16916_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2011.08.132","article-title":"Radiopaque microspheres for improved transarterial chemical embolization (TACE)","volume":"152","author":"Saralidze","year":"2011","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.heliyon.2023.e16916_bib36","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1021\/bm7008334","article-title":"New intrinsically Radiopaque hydrophilic microspheres for embolization: synthesis and characterization","volume":"9","author":"van Hooy-Corstjens","year":"2007","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.heliyon.2023.e16916_bib37","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/jbm.b.34708","article-title":"Polymer microparticles with a cavity designed for transarterial chemo\u2010embolization with crystalline drug formulations","volume":"109","author":"Karina","year":"2020","journal-title":"J. Biomed. Mater. Res. B Appl. Biomater."},{"key":"10.1016\/j.heliyon.2023.e16916_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119102","article-title":"Controlled in vitro delivery of voriconazole and diclofenac to the cornea using contact lenses for the treatment of Acanthamoeba keratitis","volume":"579","author":"Morgan","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.heliyon.2023.e16916_bib39","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.progpolymsci.2011.07.006","article-title":"Porous polymer particles\u2014a comprehensive guide to synthesis, characterization, functionalization and applications","volume":"37","author":"Gokmen","year":"2012","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.heliyon.2023.e16916_bib40","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.survophthal.2003.12.009","article-title":"Determinants of eye drop size","volume":"49","author":"Van Santvliet","year":"2004","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.heliyon.2023.e16916_bib41","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jtos.2019.02.012","article-title":"Efficacy of topical ophthalmic drugs in the treatment of dry eye disease: a systematic literature review","volume":"17","author":"Holland","year":"2019","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.heliyon.2023.e16916_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2020.126190","article-title":"Multifunctional Glutathione-dependent hydrogel eye drops with enhanced drug bioavailability for glaucoma therapy","volume":"402","author":"Lai","year":"2020","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.heliyon.2023.e16916_bib43","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/pi.6489","article-title":"Highly interconnected porous monolithic and beaded polymers using high internal phase emulsion polymerization: tuning porous architecture through synthesis variables","volume":"72","author":"Ponrathnam","year":"2023","journal-title":"Polym. Int."},{"key":"10.1016\/j.heliyon.2023.e16916_bib44","doi-asserted-by":"crossref","DOI":"10.1208\/s12249-021-01977-0","article-title":"Review of approaches for increasing ophthalmic bioavailability for eye drop formulations","volume":"22","author":"Lanier","year":"2021","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.heliyon.2023.e16916_bib45","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1111\/bph.14024","article-title":"Principles of pharmacology in the eye","volume":"174","author":"Awwad","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.heliyon.2023.e16916_bib46","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1002\/jps.21200","article-title":"Molecular design for enhancement of ocular penetration","volume":"97","author":"Shirasaki","year":"2008","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/j.heliyon.2023.e16916_bib47","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.addr.2006.07.024","article-title":"Drug transport in corneal epithelium and blood\u2013retina barrier: emerging role of transporters in ocular pharmacokinetics","volume":"58","author":"Mannermaa","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.heliyon.2023.e16916_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106653","article-title":"Extended Latanoprost release from Commercial Contact Lenses: in vitro studies using corneal models","volume":"9","author":"Mohammadi","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2023.e16916_bib49","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/icb\/icu092","article-title":"Exchange of tears under a contact lens is driven by distortions of the contact lens","volume":"54","author":"Maki","year":"2014","journal-title":"Integr. Comp. Biol."},{"key":"10.1016\/j.heliyon.2023.e16916_bib50","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.clae.2015.07.007","article-title":"Structural design of contact lens-based drug delivery systems; in vitro and in vivo studies of ocular triggering mechanisms","volume":"39","author":"Mahomed","year":"2016","journal-title":"Contact Lens Anterior Eye"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023041233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023041233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:27:24Z","timestamp":1790468844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023041233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S2405844023041233"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e16916","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel approach to achieve semi-sustained drug delivery to the eye through asymmetric loading of soft contact lenses","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e16916","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e16916"}}